Issues important to the design of stroke recovery trials
- PMID: 32085829
- DOI: 10.1016/S1474-4422(20)30030-2
Issues important to the design of stroke recovery trials
Erratum in
-
Correction to Lancet Neurol 2020; 19: 197-98.Lancet Neurol. 2020 May;19(5):e5. doi: 10.1016/S1474-4422(20)30103-4. Lancet Neurol. 2020. PMID: 32333901 No abstract available.
Comment in
-
Refining endpoints for stroke recovery trials.Lancet Neurol. 2020 May;19(5):381-382. doi: 10.1016/S1474-4422(20)30101-0. Lancet Neurol. 2020. PMID: 32333891 No abstract available.
Comment on
-
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.Lancet Neurol. 2020 Mar;19(3):226-233. doi: 10.1016/S1474-4422(20)30004-1. Lancet Neurol. 2020. PMID: 32085836 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
